Recurrent Non-Small Lung Cell Cancer
1 clinical trials · Condition
◉ Watch Recurrent Non-Small Lung Cell Cancer
| Record | Firm | Date |
|---|---|---|
| Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade (NCT04340882) | Emory University | 2020-06-05 |
Track Recurrent Non-Small Lung Cell Cancer automatically
Every clearance here is in the API, with alerts when new ones post.